摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-氯-4-甲基苯磺酸 | 98-34-0

中文名称
3-氯-4-甲基苯磺酸
中文别名
——
英文名称
3-chloro-4-methylbenzenesulfonic acid
英文别名
3-chloro-4-methyl-benzenesulfonic acid;3-chloro-4-methylbenzenesulphonic acid;2-chloro-4-toluenesulfonic acid;CMBSA;2-chloro-toluene-4-sulfonic acid;2-Chlor-toluol-4-sulfonsaeure;Benzenesulfonic acid, 3-chloro-4-methyl-
3-氯-4-甲基苯磺酸化学式
CAS
98-34-0
化学式
C7H7ClO3S
mdl
——
分子量
206.65
InChiKey
UPMIEBBZKWZYEZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    62.8
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2904909090

SDS

SDS:c0a4e58edce0b82264d138a3c66078a1
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-氯-4-甲基苯磺酸喹啉硫酸copper(II) oxide 作用下, 反应 3.0h, 以95%的产率得到2-氯甲苯
    参考文献:
    名称:
    Highly Selective Oxidative Monochlorination To Synthesize Organic Intermediates: 2-Chlorotoluene, 2-Chloroaniline, 2-Chlorophenol, and 2-Chloro-4-methylphenol
    摘要:
    An alternative manufacturing process scheme was developed to synthesize monochloro-substituted aromatic compounds in high selectivity, involving oxidative chlorination by using HCl-H2O2. Thus, 2-chlorotoluene, 2-chloroaniline, and 2-chlorophenol were synthesized by oxidative chlorination followed by desulphonation or decarboxylation, Oxidative chlorination of 4-methylbenzenesulphonic acid, 4-methylbenzoic acid, 4-aminobenzoic acid, and l-hydroxybenzoic acid by using a suitable ratio of reactant:HCl:H2O2, and their subsequent desulphonation or decarboxylation, gave 60-85% yield of the desired products. Oxidative chlorination of 4-methylphenol by using HCl-H2O2 gave as high as 98% selectivity to the desired 2-chloro-4-methylphenol.
    DOI:
    10.1021/op980083s
  • 作为产物:
    描述:
    alkaline earth salt of/the/ methylsulfuric acid 在 盐酸 作用下, 生成 3-氯-4-甲基苯磺酸
    参考文献:
    名称:
    Limpricht; Paysan, Justus Liebigs Annalen der Chemie, 1883, vol. 221, p. 212
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • JAK INHIBITOR
    申请人:Kyowa Hakko Kirin Co., Ltd.
    公开号:EP2108642A1
    公开(公告)日:2009-10-14
    A JAK inhibitor comprising, as an active ingredient, a nitrogen-containing heterocyclic compound represented by formula (I) wherein W represents a nitrogen atom or -CH-; X represents -C (=O) - or -CHR4- (wherein R4 represents a hydrogen atom, or the like); R1 represents the formula described below [wherein Q1 represents-CR8-(wherein R8 represents a hydrogen atom, substituted or unsubstituted lower alkyl, or the like); Q2 represents -NR15- (wherein R15 represents a hydrogen atom, substituted or unsubstituted lower alkyl, or the like); and R5 and R6 may be the same or different and each represents a hydrogen atom, halogen, carboxy, substituted or unsubstituted lower alkyl, or the like], or the like; and R2 and R3 may be the same or different and each represents a hydrogen atom, halogen, substituted or unsubstituted lower alkyl, or the like} or a pharmaceutically acceptable salt thereof.
    一种JAK抑制剂,其作为活性成分的是由式(I)表示的含氮杂环化合物 其中W代表氮原子或-CH-; X代表-C(=O)-或-CHR4-(其中R4代表氢原子或类似物); R1代表下述式[其中Q1代表-CR8-(其中R8代表氢原子、取代或未取代的较低烷基或类似物); Q2代表-NR15-(其中R15代表氢原子、取代或未取代的较低烷基或类似物);而R5和R6可以相同也可以不同,每个代表氢原子、卤素、羧基、取代或未取代的较低烷基或类似物,或类似物;而 R2和R3可以相同也可以不同,每个代表氢原子、卤素、取代或未取代的较低烷基或类似物}或其药学上可接受的盐。
  • LEUCO COMPOUNDS
    申请人:Milliken & Company
    公开号:US20190112488A1
    公开(公告)日:2019-04-18
    A compound comprises at least one fluorescent moiety covalently bound to at least one second moiety selected from the group consisting of leuco moieties and chromophore moieties.
    一个化合物至少包括一个共价结合至来自亮色基团和色团基团组成的羟基团中的至少一个第二基团的荧光基团。
  • LEUCO TRIPHENYLMETHANE COLORANTS AS BLUING AGENTS IN LAUNDRY CARE COMPOSITIONS
    申请人:The Procter & Gamble Company
    公开号:US20180119058A1
    公开(公告)日:2018-05-03
    A laundry care composition including: (a) at least one laundry care ingredient and (b) a least one compound represented by Formula (I): The ratio of Formula I to its oxidized form is at least 1:3 and each individual R o , R m and R p group on each of rings A, B and C is independently selected from the group consisting of hydrogen, deuterium and R 5 . At least one of the R o and R m groups on at least one of the three rings A, B or C is hydrogen and each R p is independently selected from hydrogen, —OR 1 and —NR 1 R 2 . G is independently selected from the group consisting of hydrogen, deuterium, and mixtures thereof. Methods of treating textiles with such detergent compositions.
    一种洗涤护理组合物,包括:(a)至少一种洗涤护理成分和(b)至少一种由公式(I)表示的化合物: 公式I与其氧化形式的比率至少为1:3,并且每个环A、B和C上的每个单独的Ro,Rm和Rp组独立地选自包括氢、氘和R5的组。至少一个环A、B或C上的至少一个Ro和Rm组是氢,并且每个Rp独立地选自氢、—OR1和—NR1R2。G独立地选自包括氢、氘和它们的混合物的组。处理纺织品的方法与这样的洗涤剂组合物。
  • NOVEL NITROGENOUS COMPOUND AND USE THEREOF
    申请人:Kureha Chemical Industry Co., Ltd.
    公开号:EP1431290A1
    公开(公告)日:2004-06-23
    A novel nitrogen-containing compound effective against diseases such as HIV viral infectious diseases, rheumatism, and cancerous metastasis. It is a nitrogen-containing compound represented by the following general formula (1). In the formula, A typically represents a group represented by the formula (2) (A1 is hydrogen or an optionally substituted, mono- or polycyclic, heteroaromatic or aromatic ring; G1 is a single bond or a hydrocarbon group represented by the following formula (3) wherein R1, R2, and R3 may be optionally substituted hydrocarbon groups); W is an optionally substituted hydrocarbon group or heterocyclic ring; x is -C(=O)NH-; y is -C(=O)-; and D1 is hydrogen atom, alkyl having a polycyclic aromatic ring, di (substituted alkyl)amine, or alicyclic amine.
    一种新型含氮化合物,对HIV病毒感染性疾病、风湿病和癌细胞转移等疾病具有有效作用。它是一种由下述通用式(1)表示的含氮化合物。在该式中,A通常表示由式(2)表示的基团(A1是氢或可选择取代的单环或多环杂环芳香环;G1是单键或由下述式(3)表示的碳氢基团,其中R1、R2和R3可能是可选择取代的碳氢基团);W是可选择取代的碳氢基团或杂环环;x是-C(=O)NH-;y是-C(=O)-;D1是氢原子、具有多环芳香环的烷基、二(取代烷基)胺或脂环胺。
  • Studies of hypolipidemic agents. I. Syntheses and hypolipidemic activities of 1-substituted 2-alkanone derivatives.
    作者:KAZUO OGAWA、TADAFUMI TERADA、YOSHIYUKI MURANAKA、TOSHIHIRO HAMAKAWA、SADAO HASHIMOTO、SETSURO FUJII
    DOI:10.1248/cpb.34.1118
    日期:——
    Many 1-substituted 2-alkanone derivatives were synthesized and their inhibitory activities toward pancreatic lipase and esterase were examined in order to obtain hypolipidemic agents. 1-Benzenesulfonyloxy-2-pentanone (VI-2a) and 1-(2, 4, 6-trimethylbenzenesulfonyloxy)-2-pentanone (VI-2q) exhibited not only potent and selective esterase inhibitions (IC50 : 9.0×10-7M and 1.0×10-6M, respectively), but also potent hypolipidemic action (90 and 92% reductions of plasma triglyceride, and 53 and 90% reductions of plasma total cholesterol, respectively). A novel working hypothesis is presented to account for the lowering of the plasma lipids level, i.e., that inhibition of esterase and lipase activities in the small intestinal lumen may be responsible for the decrease in the plasma lipids level.
    合成了许多1-取代的2-酮烷基衍生物,并考察了它们对胰脂肪酶和酯酶的抑制活性,以期获得降脂药物。1-苯磺酰氧基-2-戊酮(VI-2a)和1-(2, 4, 6-三甲基苯磺酰氧基)-2-戊酮(VI-2q)不仅表现出显著且具有选择性的酯酶抑制(IC50:9.0×10^-7M 和 1.0×10^-6M),而且还具有强效的降脂作用(血浆甘油三脂分别减少90%和92%,血浆总胆固醇分别减少53%和90%)。提出了一个新的工作假设来解释血浆脂质水平的降低,即小肠腔内酯酶和脂肪酶活性的抑制可能是导致血浆脂质水平下降的原因。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐